All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Introducing
Now you can personalise
your ALL Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The ALL Hub is an independent medical education platform, sponsored by Jazz Pharmaceuticals, Amgen, and Pfizer. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Wendy Stock is a professor of medicine specializing in hematology/oncology at the University of Chicago, US. Her areas of expertise include acute leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myelodysplastic syndromes, adolescent and young adult cancer care, CAR (chimeric antigen receptor) T-cell therapy, and stem cell transplant. Wendy is a co-leader of the University of Chicago Cancer Research Center’s Program in Hematopoiesis and Hematological Malignancies and is a core member of the Leukemia and Leukemia Correlative Sciences Committees in the Alliance, a NCI-sponsored clinical trials cooperative group. Additionally, Wendy is co-chair of the NCI National Clinical Trials Network (NCTN) Leukemia Steering Committee.